- FDA’s current expanded access policies, requirements for enrolling in expanded access programs, and steps you can take to get more information.
- To view the February 18, 2015, 2015 Newsletter.
- April 2, 2015 from 1:00pm to 5:00pm
- What patients need to know.
Navigate the For Patients Section
Learn about the Patient Representative Program and other ways that the FDA is working with patients and their community.Calendar of Public Meetings
Find upcoming FDA sponsored public meetings and advisory committee meetings.Comment on Current FDA Draft Guidances
Submit your comments on draft guidances and other policy related questions that affect patients.Get Illness/Condition Information
FDA brings the patient perspective into the review of medical products that treat Cancer, Cardiovascular disease, Diabetes, Hepatitis B & C, HIV/AIDS and other illnesses.
Clinical trials, informed consent and FDA's role in ensuring that people of different demographics are included in clinical trials.Learn About Drug and Device Approvals
FDA is speeding up the approval process for Drugs and Medical Devices.Learn About Other Treatment Options
Expanded access, investigational new drugs and off-label use of approved products.
FDA Patient Specific E-mail List serves
- FDA's Patient Network Newsletter
Sign Up for our bi-weekly email newsletter that provides information about product safety, drug shortages, product approvals, upcoming meetings, and more.
Updates on safety and regulatory issues related to Cardiovascular Disease, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
- FDA Diabetes Monitor
Updates on safety and regulatory issues related to Diabetes, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
Hepatitis B and C Updates
Late breaking information, as well as an archival record of updates on safety and regulatory issues related to Hepatitis B and C
Updates on important safety and regulatory issues related to HIV, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
FDA Office of Minority Health Email Updates
Updates on health and safety information that are important to minority communities, and a quarterly newsletter detailing upcoming issues and opportunities for you to inform future directions in research.
Subscribe to MedWatch Safety Aletrts
Safety alerts delivered to your inbox. To subscribe, just provide your e-mail address. E-list managed by GovDelivery.